Acelrx to host full year and fourth quarter 2022 financial results call and webcast on march 30, 2023

Hayward, calif. , march 21, 2023 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will release full year and fourth quarter financial results for 2022 after the market close on thursday, march 30, 2023.
ACRX Ratings Summary
ACRX Quant Ranking